A detailed history of Alpha Centric Advisors LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 9,000 shares of LNTH stock, worth $803,610. This represents 0.83% of its overall portfolio holdings.

Number of Shares
9,000
Holding current value
$803,610
% of portfolio
0.83%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$77.7 - $123.62 $699,300 - $1.11 Million
9,000 New
9,000 $987,000
Q1 2023

May 12, 2023

BUY
$47.76 - $82.86 $286,560 - $497,160
6,000 Added 35.29%
23,000 $1.9 Million
Q4 2022

Feb 07, 2023

BUY
$48.76 - $77.67 $828,920 - $1.32 Million
17,000 New
17,000 $866,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.